FLY-GEN is a spin-off startup aiming to deliver a new solution of natural active compounds, drug discovery, protein design and analytical research of natural products in regenerating medicine. It was co-founded by four specialists of the Biotech area. We focus on scientific software development, in silico modelling, and applied engineering of antibacterial peptides as well as recombinant enzymes strictly targeting dead tissues of non-healing wounds.